06/04/2024 | Press release | Distributed by Public on 06/03/2024 22:06
This material is intended to notify the press release issued on May 29 (local time) by Bristol Myers Squibb, our license partner for Opdivo.
Please click https://www.bms.com/media/press-releases.html for the original press release.